240 related articles for article (PubMed ID: 36032172)
1. Complement lectin pathway components MBL and MASP-1 promote haemostasis upon vessel injury in a microvascular bleeding model.
Golomingi M; Kohler J; Jenny L; Hardy ET; Dobó J; Gál P; Pál G; Kiss B; Lam WA; Schroeder V
Front Immunol; 2022; 13():948190. PubMed ID: 36032172
[TBL] [Abstract][Full Text] [Related]
2. Complement inhibition can decrease the haemostatic response in a microvascular bleeding model at multiple levels.
Golomingi M; Kohler J; Lamers C; Pouw RB; Ricklin D; Dobó J; Gál P; Pál G; Kiss B; Dopler A; Schmidt CQ; Hardy ET; Lam W; Schroeder V
Front Immunol; 2023; 14():1226832. PubMed ID: 37771595
[TBL] [Abstract][Full Text] [Related]
3. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.
Kozarcanin H; Lood C; Munthe-Fog L; Sandholm K; Hamad OA; Bengtsson AA; Skjoedt MO; Huber-Lang M; Garred P; Ekdahl KN; Nilsson B
J Thromb Haemost; 2016 Mar; 14(3):531-45. PubMed ID: 26614707
[TBL] [Abstract][Full Text] [Related]
4. Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot.
Gulla KC; Gupta K; Krarup A; Gal P; Schwaeble WJ; Sim RB; O'Connor CD; Hajela K
Immunology; 2010 Apr; 129(4):482-95. PubMed ID: 20002787
[TBL] [Abstract][Full Text] [Related]
5. Co-complexes of MASP-1 and MASP-2 associated with the soluble pattern-recognition molecules drive lectin pathway activation in a manner inhibitable by MAp44.
Degn SE; Jensen L; Olszowski T; Jensenius JC; Thiel S
J Immunol; 2013 Aug; 191(3):1334-45. PubMed ID: 23785123
[TBL] [Abstract][Full Text] [Related]
6. MASP-1 of the complement system enhances clot formation in a microvascular whole blood flow model.
Jenny L; Dobó J; Gál P; Pál G; Lam WA; Schroeder V
PLoS One; 2018; 13(1):e0191292. PubMed ID: 29324883
[TBL] [Abstract][Full Text] [Related]
7. Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway.
Takahashi M; Iwaki D; Kanno K; Ishida Y; Xiong J; Matsushita M; Endo Y; Miura S; Ishii N; Sugamura K; Fujita T
J Immunol; 2008 May; 180(9):6132-8. PubMed ID: 18424734
[TBL] [Abstract][Full Text] [Related]
8. The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway.
Iwaki D; Kanno K; Takahashi M; Endo Y; Matsushita M; Fujita T
J Immunol; 2011 Oct; 187(7):3751-8. PubMed ID: 21865552
[TBL] [Abstract][Full Text] [Related]
9. Mannose-binding lectin-associated serine protease-1 is a significant contributor to coagulation in a murine model of occlusive thrombosis.
La Bonte LR; Pavlov VI; Tan YS; Takahashi K; Takahashi M; Banda NK; Zou C; Fujita T; Stahl GL
J Immunol; 2012 Jan; 188(2):885-91. PubMed ID: 22156595
[TBL] [Abstract][Full Text] [Related]
10. Dissociation and re-association studies on the interaction domains of mannan-binding lectin (MBL)-associated serine proteases, MASP-1 and MASP-2, provide evidence for heterodimer formation.
Paréj K; Hermann A; Donáth N; Závodszky P; Gál P; Dobó J
Mol Immunol; 2014 May; 59(1):1-9. PubMed ID: 24424083
[TBL] [Abstract][Full Text] [Related]
11. The emerging roles of mannose-binding lectin-associated serine proteases (MASPs) in the lectin pathway of complement and beyond.
Dobó J; Pál G; Cervenak L; Gál P
Immunol Rev; 2016 Nov; 274(1):98-111. PubMed ID: 27782318
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus.
Neth O; Jack DL; Johnson M; Klein NJ; Turner MW
J Immunol; 2002 Oct; 169(8):4430-6. PubMed ID: 12370377
[TBL] [Abstract][Full Text] [Related]
13. Quantitative characterization of the activation steps of mannan-binding lectin (MBL)-associated serine proteases (MASPs) points to the central role of MASP-1 in the initiation of the complement lectin pathway.
Megyeri M; Harmat V; Major B; Végh Á; Balczer J; Héja D; Szilágyi K; Datz D; Pál G; Závodszky P; Gál P; Dobó J
J Biol Chem; 2013 Mar; 288(13):8922-34. PubMed ID: 23386610
[TBL] [Abstract][Full Text] [Related]
14. A journey through the lectin pathway of complement-MBL and beyond.
Garred P; Genster N; Pilely K; Bayarri-Olmos R; Rosbjerg A; Ma YJ; Skjoedt MO
Immunol Rev; 2016 Nov; 274(1):74-97. PubMed ID: 27782323
[TBL] [Abstract][Full Text] [Related]
15. Serum MASP-1 in complex with MBL activates endothelial cells.
Megyeri M; Jani PK; Kajdácsi E; Dobó J; Schwaner E; Major B; Rigó J; Závodszky P; Thiel S; Cervenak L; Gál P
Mol Immunol; 2014 May; 59(1):39-45. PubMed ID: 24472859
[TBL] [Abstract][Full Text] [Related]
16. Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation.
Takahashi K; Chang WC; Takahashi M; Pavlov V; Ishida Y; La Bonte L; Shi L; Fujita T; Stahl GL; Van Cott EM
Immunobiology; 2011; 216(1-2):96-102. PubMed ID: 20399528
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in mannan-binding lectin (MBL)-associated serine protease 2 affect stability, binding to MBL, and enzymatic activity.
Thiel S; Kolev M; Degn S; Steffensen R; Hansen AG; Ruseva M; Jensenius JC
J Immunol; 2009 Mar; 182(5):2939-47. PubMed ID: 19234189
[TBL] [Abstract][Full Text] [Related]
18. Small mannose-binding lectin-associated protein plays a regulatory role in the lectin complement pathway.
Iwaki D; Kanno K; Takahashi M; Endo Y; Lynch NJ; Schwaeble WJ; Matsushita M; Okabe M; Fujita T
J Immunol; 2006 Dec; 177(12):8626-32. PubMed ID: 17142762
[TBL] [Abstract][Full Text] [Related]
19. Effects of MASP-1 of the complement system on activation of coagulation factors and plasma clot formation.
Hess K; Ajjan R; Phoenix F; Dobó J; Gál P; Schroeder V
PLoS One; 2012; 7(4):e35690. PubMed ID: 22536427
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional overview of the lectin complement pathway: its molecular basis and physiological implication.
Matsushita M; Endo Y; Fujita T
Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):273-83. PubMed ID: 23563865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
